Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
112.50
-0.50 (-0.44%)
Sep 12, 2025, 3:00 PM CST
SHA:688266 Market Cap
SHA:688266 has a market cap or net worth of 29.78 billion as of September 12, 2025. Its market cap has increased by 92.54% in one year.
Market Cap
29.78B
Enterprise Value
28.77B
Revenue
667.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
112.50
Market Cap Chart
Since January 23, 2020, SHA:688266's market cap has increased from 17.90B to 29.78B, an increase of 66.35%. That is a compound annual growth rate of 9.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 12, 2025 | 29.78B | 80.55% |
Dec 31, 2024 | 16.49B | 17.70% |
Dec 29, 2023 | 14.01B | 40.02% |
Dec 30, 2022 | 10.01B | -29.08% |
Dec 31, 2021 | 14.11B | -9.10% |
Dec 31, 2020 | 15.53B | -13.27% |
Jan 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 459.54B |
WuXi AppTec | 307.21B |
Shenzhen Mindray Bio-Medical Electronics | 291.45B |
Sichuan Biokin Pharmaceutical | 140.27B |
Shanghai United Imaging Healthcare | 123.91B |
Zhangzhou Pientzehuang Pharmaceutical., | 122.62B |
Aier Eye Hospital Group | 119.82B |
Yunnan Baiyao Group Co.,Ltd | 105.25B |